Literature DB >> 22488525

Sex differences in molecular and cellular substrates of stress.

Debra A Bangasser1, Rita J Valentino.   

Abstract

Women are twice as likely as men to suffer from stress-related psychiatric disorders, like unipolar depression and post-traumatic stress disorder. Although the underlying neural mechanisms are not well characterized, the pivotal role of stress in the onset and severity of these diseases has led to the idea that sex differences in stress responses account for this sex bias. Corticotropin-releasing factor (CRF) orchestrates stress responses by acting both as a neurohormone to initiate the hypothalamic-pituitary-adrenal (HPA) axis and as a neuromodulator in the brain. One target of CRF modulation is the locus coeruleus (LC)-norepinephrine system, which coordinates arousal components of the stress response. Hypersecretion of CRF and dysregulation of targets downstream from CRF, such as the HPA axis and LC-norepinephrine system, are characteristic features of many stress-related psychiatric diseases, suggesting a causal role for CRF and its targets in the development of these disorders. This review will describe sex differences in CRF and the LC-norepinephrine system that can increase stress sensitivity in females, making them vulnerable to stress-related disorders. Evidence for gonadal hormone regulation of hypothalamic CRF is discussed as an effect that can lead to increased HPA axis activity in females. Sex differences in the structure of LC neurons that create the potential for hyperarousal in response to emotional stimuli are described. Finally, sex differences at the molecular level of the CRF(1) receptor that make the LC-norepinephrine system more reactive in females are reviewed. The implications of these sex differences for the treatment of stress-related psychiatric disorders also will be discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488525      PMCID: PMC3378920          DOI: 10.1007/s10571-012-9824-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  176 in total

1.  Elevated concentrations of CRF in the locus coeruleus of depressed subjects.

Authors:  Garth Bissette; Violetta Klimek; Jun Pan; Craig Stockmeier; Gregory Ordway
Journal:  Neuropsychopharmacology       Date:  2003-05-21       Impact factor: 7.853

2.  Variations in hepatic inactivation of corticosterone with changes in food intake: an explanation of impaired corticosteroid metabolism following noxious stimuli.

Authors:  A L HERBST; F E YATES; D W GLENISTER; J URQUHART
Journal:  Endocrinology       Date:  1960-08       Impact factor: 4.736

3.  Differential regulation of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-arrestins and Rab GTPases.

Authors:  Kevin D Holmes; Andy V Babwah; Lianne B Dale; Michael O Poulter; Stephen S G Ferguson
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

4.  Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus.

Authors:  Beverly A S Reyes; Krysta Fox; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Eur J Neurosci       Date:  2006-06       Impact factor: 3.386

5.  Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity.

Authors:  A L Curtis; S M Lechner; L A Pavcovich; R J Valentino
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

6.  Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men.

Authors:  M C Austin; J E Janosky; H A Murphy
Journal:  Mol Psychiatry       Date:  2003-03       Impact factor: 15.992

7.  Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects.

Authors:  Frederic J Sautter; Garth Bissette; Justin Wiley; Gina Manguno-Mire; Benjamin Schoenbachler; Leann Myers; Janet E Johnson; Arleen Cerbone; Dolores Malaspina
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

8.  Androgen inhibits the increases in hypothalamic corticotropin-releasing hormone (CRH) and CRH-immunoreactivity following gonadectomy.

Authors:  E W Bingaman; D J Magnuson; T S Gray; R J Handa
Journal:  Neuroendocrinology       Date:  1994-03       Impact factor: 4.914

Review 9.  Therapeutic potential of β-arrestin- and G protein-biased agonists.

Authors:  Erin J Whalen; Sudarshan Rajagopal; Robert J Lefkowitz
Journal:  Trends Mol Med       Date:  2010-12-21       Impact factor: 11.951

10.  Postnatal masculinization alters the HPA axis phenotype in the adult female rat.

Authors:  J V Seale; S A Wood; H C Atkinson; M S Harbuz; S L Lightman
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

View more
  65 in total

Review 1.  Cellular and molecular mechanisms of sexual differentiation in the mammalian nervous system.

Authors:  Nancy G Forger; J Alex Strahan; Alexandra Castillo-Ruiz
Journal:  Front Neuroendocrinol       Date:  2016-01-11       Impact factor: 8.606

Review 2.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

Review 3.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

Review 4.  Sex dimorphism in seizure-controlling networks.

Authors:  Fillippo Sean Giorgi; Aristea S Galanopoulou; Solomon L Moshé
Journal:  Neurobiol Dis       Date:  2014-05-20       Impact factor: 5.996

Review 5.  Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones.

Authors:  S Bradley King; Donna J Toufexis; Sayamwong E Hammack
Journal:  Stress       Date:  2017-06-14       Impact factor: 3.493

Review 6.  The neuroanatomic complexity of the CRF and DA systems and their interface: What we still don't know.

Authors:  E A Kelly; J L Fudge
Journal:  Neurosci Biobehav Rev       Date:  2018-04-25       Impact factor: 8.989

Review 7.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

8.  Palatable food avoidance and acceptance learning with different stressors in female rats.

Authors:  N-C Liang; M E Smith; T H Moran
Journal:  Neuroscience       Date:  2013-02-01       Impact factor: 3.590

Review 9.  Stress is a principal factor that promotes tobacco use in females.

Authors:  Oscar V Torres; Laura E O'Dell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-22       Impact factor: 5.067

10.  Essential Role of Ovarian Hormones in Susceptibility to the Consequences of Witnessing Social Defeat in Female Rats.

Authors:  Julie E Finnell; Brandon L Muniz; Akhila R Padi; Calliandra M Lombard; Casey M Moffitt; Christopher S Wood; L Britt Wilson; Lawrence P Reagan; Marlene A Wilson; Susan K Wood
Journal:  Biol Psychiatry       Date:  2018-01-31       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.